Biocon Limited
BIOCON
Rank in Stocks
#3390
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Share Price
$3.76
Market Cap
$5.14B
Change (1 day)
-2.11%
Change (1 year)
-7.08%
Country
IN
Trade Biocon Limited (BIOCON)
Category
Healthcare
Earnings for Biocon Limited (BIOCON)
Earnings in Jun 2026 TTM: $52.82M
According to Biocon Limited latest financial reports the company's current earnings are $52.82M. In 2024 the company made an earning of $182.91M, an increase over its 2023 earnings that were of $109.16M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Biocon Limited from 2004 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $52.82M | -76.06% |
| 2025 | $220.59M | 20.60% |
| 2024 | $182.91M | 67.56% |
| 2023 | $109.16M | -15.71% |
| 2022 | $129.51M | -11.21% |
| 2021 | $145.85M | -9.56% |
| 2020 | $161.27M | -7.82% |
| 2019 | $174.96M | 86.74% |
| 2018 | $93.69M | -28.50% |
| 2017 | $131.03M | 15.54% |
| 2016 | $113.40M | 13.38% |
| 2015 | $100.02M | -3.94% |
| 2014 | $104.12M | -7.29% |
| 2013 | $112.30M | 45.09% |
| 2012 | $77.40M | -22.86% |
| 2011 | $100.34M | 28.22% |
| 2010 | $78.26M | 52.81% |
| 2009 | $51.21M | -11.25% |
| 2008 | $57.70M | 18.55% |
| 2007 | $48.67M | 7.03% |
| 2006 | $45.48M | -7.69% |
| 2005 | $49.26M | 32.27% |
| 2004 | $37.24M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $5.27B | 9,886.99% |
US
|
|
| $-3.09B | -5,944.63% |
US
|
|
| $-4.02B | -7,703.88% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | 3,593.17% |
NL
|
